Furosemide and spironolactone doses and hyponatremia in patients with heart failure

被引：0
|
作者：
Ivan Velat
Željko Bušić
Marina Jurić Paić
Viktor Čulić
机构：
[1] University Hospital Center Split,Department of Cardiology
[2] University Hospital Center Split,undefined
[3] University of Split School of Medicine,undefined
来源：
BMC Pharmacology and Toxicology | / 21卷
关键词：
Hyponatremia; Heart failure; Diuretics; Furosemide; Spironolactone;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Furosemide and spironolactone doses and hyponatremia in patients with heart failure
    Velat, Ivan
    Busic, Zeljko
    Paic, Marina Juric
    Culic, Viktor
    BMC PHARMACOLOGY & TOXICOLOGY, 2020, 21 (01)
  • [2] Spironolactone, not furosemide, improved insulin resistance in patients with chronic heart failure
    Ogino, Kazuhide
    Kinugasa, Yoshiharu
    Kato, Masahiko
    Yamamoto, Kazuhiro
    Hisatome, Ichiro
    Anker, Stefan D.
    Doehner, Wolfram
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 171 (03) : 398 - 403
  • [3] Hyponatremia in patients with heart failure
    Filippatos, Theodosios D.
    Elisaf, Moses S.
    WORLD JOURNAL OF CARDIOLOGY, 2013, 5 (09): : 317 - 328
  • [4] Hyponatremia in Patients with Heart Failure: a Prognostic Marker
    Diaconu, Camelia Cristina
    Manea, Maria
    Iancu, Mihaela Adela
    Alexandra Stanescu, Ana Maria
    Socea, Bogdan
    Spinu, Dan Arsenie
    Marcu, Dragos
    Bratu, Ovidiu Gabriel
    REVISTA DE CHIMIE, 2018, 69 (05): : 1071 - 1074
  • [5] Diabetic patients need higher furosemide doses: a report on acute and chronic heart failure patients
    Cunha, Filipe M.
    Pereira, Joana
    Marques, Pedro
    Ribeiro, Ana
    Bettencourt, Paulo
    Lourenco, Patricia
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2020, 21 (01) : 21 - 26
  • [6] Clinical effects of combined treatment by optimal dose of furosemide and spironolactone on diastolic heart failure in elderly patients
    Chen, Zhi-Hao
    Jiang, Yu-Rong
    Peng, Jia-Qin
    Ding, Jia-Wang
    Li, Song
    Yang, Jian
    Wu, Hui
    Yang, Jun
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 11 (03) : 890 - 894
  • [7] Spironolactone use in patients with heart failure
    Trujillo, JM
    Gonyeau, MJ
    DiVall, MV
    Alexander, SL
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2004, 29 (02) : 165 - 170
  • [8] Tolvaptan vs. furosemide-based diuretic regimens in patients hospitalized for heart failure with hyponatremia (AQUA-AHF)
    Ng, Tien M. H.
    Grazette, Luanda P.
    Fong, Michael W.
    Yoon, Andrew J.
    Lou, Mimi
    Kuo, Allen
    Upadhyay, Rani Y.
    Han, Emily E.
    Mehra, Anilkumar
    Elkayam, Uri
    ESC HEART FAILURE, 2020, 7 (04): : 1927 - 1934
  • [9] Managing Hyponatremia in Patients With Heart Failure
    Greenberg, Barry
    JOURNAL OF HOSPITAL MEDICINE, 2010, 5 : S33 - S39
  • [10] The safety of spironolactone treatment in patients with heart failure
    Anton, C
    Cox, AR
    Watson, RDS
    Ferner, RE
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2003, 28 (04) : 285 - 287
12345